Zai Lab Announces Participation in March Investor Conferences

SHANGHAI and CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), today announced that members of the company’s senior management team will participate in the following investor conferences in March 2023:

Jefferies 2023 Biotech on the Bay SummitPanel Discussion: Thursday, March 16, 2023, 12:15 p.m. ETLocation: Miami

26th Credit Suisse Asian Investment ConferenceDate: Monday, March 20 to Thursday, March 23, 2023Location: Hong Kong

About Zai Lab

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world. Our goal is to leverage our competencies and resources to positively impact human health worldwide.

For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

Investor Relations: Lina Zhang+86 136 8257 6943[email protected]

Media: Christine Drury / Xiaoyu Chen+1 (317) 385-9227 / +86 185 0015 5011[email protected] / [email protected]

You May Also Be Interested In

• Invest In the USA (IIUSA) Submits Comprehensive Comments on DHS EB-5 Notice of Proposed Rulemaking
• New Shareholder Structure and Governance at Racing Club de Lens
• The Most Important Commute by Zum Founder and CEO Ritu Narayan Named #1 Amazon Bestseller in Education Administration